Production line at Lonza’s site in Geleen will complement the existing production network and support the manufacture of up to an additional 300 million doses per year
The company's operating revenue for Q4 FY21 was Rs. 330.2 crore
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The company plans to enter the EU markets in FY22
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
Dr. Reddy's has the rights to distribute 250mn doses in India
India sales grew 23.5% YoY with consolidation of Wockhardt products
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
